Avraham Pharmaceuticals

Avraham Pharmaceuticals is a privately held pharmaceutical company that focuses on developing innovative products for the treatment and prevention of neurodegenerative disorders. Founded in 2010, the company has successfully raised $9 million to conduct a Phase II proof-of-concept efficacy trial in patients with Alzheimer's disease. Their lead product candidate, ladostigil, shows promising potenti...